What if a treatment could go beyond just slowing cognitive decline… to restoring and sustaining memory?

Developing a first-in-class therapy to restore cognition in Alzheimer Disease

Casp-Aid is Advancing a Safe, Well-Characterized Small Molecule (CIM765) into Phase II Clinical Evaluation of Cognitive Impairment in Alzheimer Disease